Literature DB >> 19322574

Predicting fetal asphyxia in intrahepatic cholestasis of pregnancy.

Deniz Oztekin1, Ipek Aydal, Ozgur Oztekin, Sabriye Okcu, Rengin Borekci, Sivekar Tinar.   

Abstract

PURPOSE: Intrahepatic cholestasis of pregnancy (ICP) is a disease associated with high-perinatal morbidity and mortality rates. It is important to have parameters that aid in predicting fetal outcomes. Certain parameters affecting asphyxia in newborns to mothers with ICP are evaluated in this study.
METHODS: One hundred eighty-seven cholestatic pregnancies were analyzed, retrospectively. Fetal asphyxia was defined as an APGAR score of less than 7 at 5 min postpartum. Predictors of asphyxia in ICP were analyzed by binary multivariate logistic regression analysis.
RESULTS: Thirty-six of the cholestatic pregnancies ended up having an asphyctic newborn at the time of delivery (19.2%). There was a statistically significance difference in the levels of total bile acids (TBA) (42.4 +/- 15.2 vs. 33.8 +/- 12.9 micromol/L, P < 0.01), HDL cholesterol (54.2 +/- 15.9 vs. 61.3 +/- 12.2, P = 0.01), total cholesterol (279.0 +/- 51.4 vs. 257.7 +/- 51.6, P = 0.02), and triacylglycerol (299.4 +/- 94.6 vs. 260.4 +/- 118.7) between the asphytic and nonasphytic group. Binary multivariate logistic regression analysis demonstrated that TBA levels (OR 1.04, 95% CI 1.01-1.08, P = 0.03) and exposure time (OR 1.11, 95% CI 1.05-1.17, P < 0.01) were the most important independent variables predicting fetal asphyxia in ICP.
CONCLUSIONS: In this study, it has been demonstrated that for the evaluation of fetal status, increased TBA levels in the mother and increased exposure time for the fetus to these increased values of TBA within the maternal circulation system help to predict increased risk of asphyxia in newborns to ICP mothers.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19322574     DOI: 10.1007/s00404-009-1052-x

Source DB:  PubMed          Journal:  Arch Gynecol Obstet        ISSN: 0932-0067            Impact factor:   2.344


  7 in total

Review 1.  [Intrahepatic cholestasis of pregnancy : Rare but important].

Authors:  A E Kremer; K Wolf; S Ständer
Journal:  Hautarzt       Date:  2017-02       Impact factor: 0.751

2.  Intrahepatic cholestasis of pregnancy: biochemical predictors of adverse perinatal outcomes.

Authors:  Hui Chen; Yuan Zhou; Dong-Rui Deng; Hai-Yan Hao; Jing Dang; Jing Li
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2013-06-17

3.  Association of severe intrahepatic cholestasis of pregnancy with adverse pregnancy outcomes: a prospective population-based case-control study.

Authors:  Victoria Geenes; Lucy C Chappell; Paul T Seed; Philip J Steer; Marian Knight; Catherine Williamson
Journal:  Hepatology       Date:  2014-02-26       Impact factor: 17.425

4.  Impacts of different methods of conception on the perinatal outcome of intrahepatic cholestasis of pregnancy in twin pregnancies.

Authors:  Chun Feng; Wen-Juan Li; Rong-Huan He; Xi-Wen Sun; Guirong Wang; Li-Quan Wang
Journal:  Sci Rep       Date:  2018-03-05       Impact factor: 4.379

5.  Can we predict severity of intrahepatic cholestasis of pregnancy using inflammatory markers?

Authors:  Çiğdem Yayla Abide; Fisun Vural; Çetin Kılıççı; Evrim Bostancı Ergen; İlter Yenidede; Ahmet Eser; Oya Pekin
Journal:  Turk J Obstet Gynecol       Date:  2017-09-30

6.  Whole-exome sequencing identifies novel mutations in ABC transporter genes associated with intrahepatic cholestasis of pregnancy disease: a case-control study.

Authors:  Xianxian Liu; Hua Lai; Siming Xin; Zengming Li; Xiaoming Zeng; Liju Nie; Zhengyi Liang; Meiling Wu; Jiusheng Zheng; Yang Zou
Journal:  BMC Pregnancy Childbirth       Date:  2021-02-05       Impact factor: 3.007

7.  Fetal cardiac dysfunction in intrahepatic cholestasis of pregnancy is associated with elevated serum bile acid concentrations.

Authors:  Tharni Vasavan; Sahil Deepak; Indu Asanka Jayawardane; Maristella Lucchini; Catherine Martin; Victoria Geenes; Joel Yang; Anita Lövgren-Sandblom; Paul Townsend Seed; Jenny Chambers; Sophia Stone; Lesia Kurlak; Peter Hendy Dixon; Hanns-Ulrich Marschall; Julia Gorelik; Lucy Chappell; Pam Loughna; Jim Thornton; Fiona Broughton Pipkin; Barrie Hayes-Gill; William Paul Fifer; Catherine Williamson
Journal:  J Hepatol       Date:  2020-12-01       Impact factor: 25.083

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.